| Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms. | |
| | |
MedLine Citation:
|
PMID: 18508981 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) has been widely used not only for detecting and staging malignant tumours but also for monitoring therapy response and for differentiating malignant lesions from benign lesions. However, the sensitivity of 18F-FDG PET for hepatocellular carcinoma (HCC) is low. Recent research about the novel drug shows that the sensitivity of 11C-acetate PET for HCC is higher than that of 18F-FDG PET and 11C-acetate also indicates tumour cell differentiation. 18F-FDG PET proved to be highly sensitive in detecting hepatic metastases from different primaries. 18F-FDG PET has also been shown to be useful and more accurate than conventional imaging modalities in demonstrating the effect of local treatments in liver tumours. With the development of small animal imaging, animal research about 18F-FDG PET is increasing. |
| | |
Authors:
|
Y-x He; Q-y Guo |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Postgraduate medical journal Volume: 84 ISSN: 1469-0756 ISO Abbreviation: Postgrad Med J Publication Date: 2008 May |
Date Detail:
|
Created Date: 2008-05-29 Completed Date: 2008-12-04 Revised Date: 2009-10-22 |
Medline Journal Info:
|
Nlm Unique ID: 0234135 Medline TA: Postgrad Med J Country: England |
Other Details:
|
Languages: eng Pagination: 246-51 Citation Subset: IM |
Affiliation:
|
Department of Radiology, The Shengjing Hospital (The Second Affiliated Hospital), China Medical University, Shenyang City, Liaoning Province, 110004, PR China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma, Hepatocellular
/
radionuclide imaging* Cholangiocarcinoma / radionuclide imaging* Fluorodeoxyglucose F18 / diagnostic use*, metabolism Humans Liver Neoplasms / radionuclide imaging*, secondary Positron-Emission Tomography / methods* Radiopharmaceuticals / diagnostic use*, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stroke in pregnancy and the puerperium.
Next Document: Management of septic arthritis: a systematic review.